StockData
Bruker Corp logo

Bruker Corp (BRKRP) KPIs and segments

BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30293% above fair value
$439.63−7.03 (-1.57%)

Close on Nov 16, 2026Market cap $9.40BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Bruker's business

Bruker's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
BSI CALID($M)
310316332313286280321279266228
BSI NANO($M)
261246309267252257318287253240
BSI BioSpin($M)
196198267209195208272233218183198
BEST($M)
74.266.871.573.866.359.372.168.769.173.175.270.6
Earlier reporting (last reported 2024)2
Product($M)
664646797691635643809709654587716615
Service and other revenue($M)
175177180169163158171155146135139128
United States($M)
248222225226223217261239244195212211
Europe excluding Germany($M)
244259272241213224287216192
Asia Pacific excluding China($M)
112135163131127131164141106
China($M)
10574138122115101114121120116167137
Germany($M)
64.462.710671.359.161.186.174.383.566.879.478
Other($M)
64.371.27469.559.966.267.573.154.659.36250.4
Earlier reporting (last reported 2025)2
BSI CALID($M)
72.362.671.77653.361.57858.758.451.180.550
BSI BioSpin($M)
41.728.86333.323.137.178.656.846.634.687.552.5
BSI NANO($M)
29.814.445.123.59.4023.144.130.619.229.858.739
BEST($M)
7.607.605.5077.2078.607.7010.68.204.409
Product($M)
331299368302289321411360328295374322
Service and other revenue($M)
84.6818177.369.370.282.258.856.257.656.760.7
BSI BioSpin($M)
0-2.40-1.10-4.80-2.30-3.20-6-13.4-3.800.40
BEST($M)
-2.80-1.60-4.50-2.10-2.40-4.80-6.30-4.20-6.30-7.60
Corporate($M)
-3.50-2.30-2.90-1.50-6.90-4.70-3.70-4.20-4-2.70
BSI CALID($M)
-6.50-6.70-4.30-7.10-5.50-8.40-15.8-6.50-6.40-5.30
BSI NANO($M)
-7.50-4.90-15.3-3.10-13.2-4.90-4.90-4.30-4-6.20
BSI BioSpin, BSI CALID, BSI NANO & Corporate($M)
5,9025,9786,0946,2876,1935,7695,6484,111
BEST($M)
194195192191191205200198179180186169
Remaining performance obligations (RPO)($M)
2,7762,7082,5692,0792,1092,0722,2072,2582,3062,189

7 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-05.

See a number that looks wrong?